LEI NIE to Drug Resistance, Neoplasm
This is a "connection" page, showing publications LEI NIE has written about Drug Resistance, Neoplasm.
Connection Strength
0.188
-
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma. Haematologica. 2023 06 01; 108(6):1616-1627.
Score: 0.081
-
Targeting PKCd as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer. Cancer Cell. 2018 12 10; 34(6):954-969.e4.
Score: 0.059
-
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma. J Clin Invest. 2023 02 01; 133(3).
Score: 0.020
-
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and S?zary Syndrome. Clin Cancer Res. 2019 12 15; 25(24):7275-7280.
Score: 0.015
-
FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma. Clin Cancer Res. 2017 Nov 15; 23(22):6759-6763.
Score: 0.013